nordazepam
This page covers all nordazepam drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Gamma-aminobutyric acid receptor subunit rho-2, Gamma-aminobutyric acid type B receptor subunit 2, GABA-A receptor alpha-1/beta-2/gamma-2.
Targets
Marketed (1)
- Praxadium · Neuroscience
Patent intelligence
- nordazepam patent landscape — aggregated cliff calendar, attackable patents, originator estates